Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP498282.RADliex-YHJXF21U0iZIwKeSe36SnPJlIe9Wrl7n3qmd8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP498282.RADliex-YHJXF21U0iZIwKeSe36SnPJlIe9Wrl7n3qmd8130_assertion type Assertion NP498282.RADliex-YHJXF21U0iZIwKeSe36SnPJlIe9Wrl7n3qmd8130_head.
- NP498282.RADliex-YHJXF21U0iZIwKeSe36SnPJlIe9Wrl7n3qmd8130_assertion description "[We measured the association of response to treatment, assessed as changes in CD4+ T cell counts after antiretroviral therapy, of five polymorphisms in four genes (CYP2B6, ABCB1/MDR1, ABCG2, and ABCC4) in which variation has been suggested to affect the pharmacokinetics of drugs commonly employed to treat HIV/AIDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498282.RADliex-YHJXF21U0iZIwKeSe36SnPJlIe9Wrl7n3qmd8130_provenance.
- NP498282.RADliex-YHJXF21U0iZIwKeSe36SnPJlIe9Wrl7n3qmd8130_assertion evidence source_evidence_literature NP498282.RADliex-YHJXF21U0iZIwKeSe36SnPJlIe9Wrl7n3qmd8130_provenance.
- NP498282.RADliex-YHJXF21U0iZIwKeSe36SnPJlIe9Wrl7n3qmd8130_assertion SIO_000772 23372834 NP498282.RADliex-YHJXF21U0iZIwKeSe36SnPJlIe9Wrl7n3qmd8130_provenance.
- NP498282.RADliex-YHJXF21U0iZIwKeSe36SnPJlIe9Wrl7n3qmd8130_assertion wasDerivedFrom befree-20140225 NP498282.RADliex-YHJXF21U0iZIwKeSe36SnPJlIe9Wrl7n3qmd8130_provenance.
- NP498282.RADliex-YHJXF21U0iZIwKeSe36SnPJlIe9Wrl7n3qmd8130_assertion wasGeneratedBy ECO_0000203 NP498282.RADliex-YHJXF21U0iZIwKeSe36SnPJlIe9Wrl7n3qmd8130_provenance.